A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 11/10/2010

Posted by | 9:41pm on Wednesday, November 10, 2010

:
Welcome to #socpharm a weekly chat where we talk pharmaceutical marketing & social media.

:
Please introduce yourself & tell us why you are interested in this topic #socpharm

:
I’m Heather Powell, in business practices and ethics at Daiichi Sankyo, part of our SM project team. #socpharm

:
@ Hello Heather! so glad you could join us. Have any topics you’d like to chat about specifically? #socpharm

:
I’m Robin Robinson, senior editor at PharmaVOICE – it’s my “beat” plus I just love it! #socpharm

:
@ Still waiting on FDA guidance. ;) Also interested in indictment against Glaxo lawyer, but that’s not related to SM! #socpharm

:
@ The FDA still has a few weeks left in 2010 right? #socpharm

:
Earlier @ asked about social media policies for pharma or supplement businesses. #socpharm

:
The only pharma co who publically shared their SM policy is @: http://bit.ly/bd4DWi #socpharm cc @

:
@ Does Daiichi have employee SM policy in place? If so, any consideration to sharing it? #socpharm

:
I’m a social media strategist, speaker, teacher (Portland State). I’m chatting w/ potential client in ancillary pharma industry. #socpharm

:
@ Unfortunately, I am not at liberty to comment on DS SM. I leave that to the professionals in Corp Comm! #socpharm

:
This helps a lot! RT @ only pharma that publically shared their SM policy is @: http://bit.ly/bd4DWi #socpharm

:
Stephany, mother/advocate interest in mental health,pharma ethics,transparency. ? AstraZeneca’s acct being locked? @ #socpharm

:
@ Interesting! What conference is #efp? #socpharm

:
Hi there- joining in a little late. I work for a Philly-based healthcare communications agency. #socpharm

:
@ @ I’m not in the ind-but do either of u think McNeil missed an opportunity to gain back cust trust? #socpharm

:
T1: What do we think constitutes an online “community” is it the ability to talk back & forth on a site? If so, only 2 in pharma #socpharm

:
@ You mean after recalls & way they handled them. Absolutely. #socpharm

:
@ T1: I do think community, at a minimum, has to involve give and take in communications. But it’s more than that . #socpharm

:
T1: It also means trust, respect, and sharing of knowledge. Otherwise, it’s just ppl shouting at and past each other. #socpharm

:
T1: Can there be a sense of community online if members can’t communicate on the site w/each other? #socpharm

:
T1: Agree with @ needs to be more than just dialogue. There needs to be some exchange/enrichment. #socpharm

:
@ @ I think of it as Peer-to Peer-consulting, patients consulting each other on treatments, coping, etc #socpharm

:
Sorry was detained by some fine wine #socpharm

:
T1: Lots of pharma sites say they r communities but don’t have interaction. Better word for these sites, that do have value? #socpharm

:
@ Fine wine? What time is it there? ;-) #socpharm

:
T1: spking 4 myself, kinda. I think of how I follow people but don’t interact with them – is it cmty? No, but it is helpful to me. #socpharm

:
Community is people listening, talking and sharing but it is defined by the community #socpharm

:
@ 5:20 at night #socpharm

:
@ Agree that these sites do have educational/info value, but feel they are misnamed by term “community” #socpharm

:
I talked to a thought leader today and he said he is really concerned about what he is finding on social media communities #socpharm

:
@ Can you elaborate? Is it misinformation that is alarming? #socpharm

:
@ What kind of thot leader and what kind of communities? #socpharm

:
@ Yes he is oncologist and said lots of misinformation about cancer and drugs #socpharm

:
T1: was motivated by looking at gr8 Dose of Digital wiki, but the list of “pharma communities” had only 2 true communities on it. #socpharm

:
@ But isn’t there also a lot of accurate info on sites like American Cancer Society? #socpharm

:
It seems as people shun from Rx because of costs they look at alternatives and lot of BS out there #socpharm

:
@ All the more reason why healthcare needs to be more proactive with SM and direct patients to the RIGHT sources. #socpharm

:
@ Yes sites like that are OK but what he said “anyone can write anything that is or isn’t true” #socpharm

:
@ I do & yes I agree – was shocked (still am) & refuse to ever purchase product knowingly #socpharm

:
@ Sounds like a good case for more physicians to get involved in SM communities for accurate/reliable info #socpharm

:
@ I agree all pharma sites should have deep links to credible information #socpharm

:
Pharma has hands tied, some of them do the best they can within murky waters of #SM, See Merck (Gardasil), See Janssen (Stelara) #socpharm

:
One post on Facebook about statins caused someone to question taking Crestor even though he had family history of heart disease #socpharm

:
Think it was @ who said do primary care docs have obligation to write about vaccines NOT causing autism & flood interwebs? #socpharm

:
RT @ It seems people shun Rx because of costs, look at alternatives & a lot of BS out there (prescriptions are costly!) #socpharm

:
@ @ I think vast majority of docs are too busy to BLOG today #socpharm

:
Can I throw a question out to the group ? #socpharm

:
@ Yes, Eileen. I often use the vaccine example to illustrate the potential power of physician influence online #socpharm

:
Absolutely. RT @: Can I throw a question out to the group ? #socpharm

:
@ If we required docs to correct all misinformation on the internet, no one would ever get to see a doctor! #socpharm

:
@ T1: not sure there can be a strong sense of community wout interaction; then just a community bec of similarities? #socpharm

:
@ I wonder if malpractice insurance cos will be driver of drs using or not using #sm to communicate w/ patients? #socpharm

:
That, plus lack of clear guidance. RT @: @ @ I think vast majority of docs are too busy 2 BLOG today #socpharm

:
@ @ Just Google I hate doctors and you’ll be surprised at all the hits #socpharm

:
RT @ @ All the more reason why healthcare needs to be more proactive with SM, direct patients to RIGHT sources #socpharm

:
@ @ Not b=necessarily..remember 90% rule, 90% read but dont post or interact #socpharm

:
@ @ Medmal carriers haven’t caught up to social media use restrictions. And I’m ready for ‘em #socpharm

:
RT @ @ Sounds like good case for more physicians to get involved in SM communities for accurate/reliable info #socpharm

:
For all you agency/consultants..what are you seeing in new business in 2011? Flat ? Increase ? #socpharm

:
Curation is the future of health information #socpharm

:
T2: RT @: For all you agency/consultants..what are you seeing in new business in 2011? Flat ? Increase ? #socpharm

:
Hi all. Frieda Hernandez lurking here form Siren Interactive interested in all things #socpharmdigpharm #fdasm #hcsm #epatient #raredisease

:
@ at end of day, “the entitlement to no risk hc in USA” is what holds back HCPs from really using #SM to improve care #socpharm

:
T2: Funny you should ask- @ is taking an agency survey with the same question #socpharm

:
RT @: Curation is the future of health information #socpharm

:
Which is why @ & http://webicina.com is so gr8 RT @: Curation is the future of health information #socpharm

:
@ Roadblocks for MDs in SoMe: Time, issues with transparency, fear of perceived risks #SocPharm

:
It seems like lots of vendor consildations and less business #socpharm

:
Si RT @: Which is y @ & http://bit.ly/aUh5A4 is so gr8 RT @: Curation is the future of health information #socpharm

:
Interesting tweet chat though no one acknowledged my presence! good luck with that #socpharm

:
T2: Fortunately, we are seeing an increase. Our business is also deepening w/existing clients. #socpharm

:
@ Sorry, didn’t mean to ignore you! Did you have a question for the gruop? #socpharm

:
Indeed RT @: Curation is the future of health information #socpharm

:
@ In #rarediseases some pharma companies use sm for this #socpharm

:
@ Is it necessary to acknowledge everyone? I think when tweetchats get busy that’s rather hard to do. #socpharm

:
My friend John Mack keeps counting down days for FDA to issue SM guidelines #socpharm

:
That makes two of us! RT @: My friend John Mack keeps counting down days for FDA to issue SM guidelines #socpharm

:
RT @: Indeed RT @: Curation is the future of health information #socpharm

:
@ Is there a specific day when FDA is supposed to issue SM guidelines? Or just vague time in the future? #socpharm

:
I am not a big believe that social media is the answer to pharma marketers needs #socpharm

:
@ Can’t name our clients, but some are doing v. nice job using listening. #socpharm

:
@ It was supposed to be this year but now they are fighting budget cuts #socpharm

:
Just joining the #socpharm chat, Spitz from Ignite Health

:
Monitoring social media “buzz” is going on, definitely #socpharm

:
T3: Anyone have any predictions on what FDA will do? I think they will allow reminder ads for black box drugs. You heard it here! #socpharm

:
Participation is scarce, genuine two-way communication virtually nonexistent #socpharm

:
dont know how many of you read post but an agency bribing pharma employees to view capabilities presentation is really new sleaze #socpharm

:
T3: By reviewing & allowing the Google PPC ads for black box drugs they have already made that switch #socpharm

:
I think FDA will issue some standardized text to enable resuscitation of the one-click rule #socpharm

:
Fingers crossed! RT @: I think FDA will issue some standardized text to enable resuscitation of the one-click rule #socpharm

:
@ To get an idea of their guidelines just look at what they want for search #socpharm

:
Fair balance templates, revealing that all drugs come with side effects, “learn more” here #socpharm

:
@ There will always be a few bad apples Rich. #socpharm

:
RT @: Anyone have predictions on what FDA will do? I think they will allow reminder ads for black box drugs. #socpharm #fdasm

:
The PPC space for pharma is dying, and non-approved herbals and remedies are rising in the ranks #socpharm

:
@ Yes and I learned today that the pharma comp sent them a nasty cease and disist letter #socpharm

:
RT @@EileenOBrien Yes and I learned today that the pharma comp sent them a nasty cease and disist letter #socpharm: @

:
The FDA understands that legit pharma is being pushed out by frauds and herbalists from Canada, and will try to help fix it #socpharm

:
@ Good for that pharmaco! #socpharm

:
@ Figured that with abdonment rate rising #socpharm

:
T3: I’m not expecting much at all from the FDA. They’re a government agency. Maximize power and minimize transparency and clarity. #socpharm

:
35 character PPC lines are not enough to show fair balance — unable to even reveal indication pharma is toast in PPC #socpharm

:
RT @: The FDA understands that legit pharma is being pushed out by frauds and herbalists and will try to help fix it #socpharm

:
@ @ Dont think they can its free speech issue #socpharm

:
By reinstating the one-click rule for fair balance information under prescribed [sic] circumstances pharma can get back on footing #socpharm

:
1 click is 2 long to get to information (FDA) #socpharm

:
What the FDA/DDMAC will NOT do is issue specific guidance by platform, i.e. Twitter or Facebook or “social media” guidance #socpharm

:
Agree-they may be going thru motions. RT @: T3: I’m not expecting much at all from the FDA. They’re a government agency. #socpharm

:
The change to the GOP in Congress will make a BIG difference for the FDA short and longer term #socpharm

:
Watch as recalls and Warning Letters plummet with the new regime in place #socpharm

:
That might influence guidance, too #socpharm

:
The FDA is now again struggling for funding #socpharm

:
@ Remember that GOP only controls the House. There is only so much u can do when u control only 1/2 of 1/3 of gov’t #socpharm

:
The GOP Congress wants to pull the plug on Obama mandated funding for the agency #socpharm

:
T3: Thought the recent article where FDA admitted they are overwhelmed was amazing:http://reut.rs/bUnTqK #socpharm

:
@ re DDMAC agree with that (and nor should they). What about guidance on off label? #socpharm

:
I think knowing what you cannot do is more important than knowing what you can. #socpharm

:
@ Knowing what you cannot do is basically all we’ve had to go by #socpharm

:
think #socpharm brought down Twitter for a min!

:
@ Thx for sharing the Reuters’ article! #socpharm

:
@: They must have had a great PR agency/in-house PR person for that placement! #socpharm

:
@ off label is verboten for pharma marketing in any and all ways #socpharm

:
@ Amen! I think that’s the million-dollar question. What can you do & stay outta trouble? #socpharm

:
Great things are only possible with outrageous requests. Who is willing ? #socpharm

:
RT @: @ Thx for sharing the Reuters article! #socpharm

:
@ it’s only going to get worse for the FDA in terms of monitoring with the new budgets #socpharm

:
Hey #socpharm! Failing to keep up w the chat while at a “team” dinner. Catchya next week.

:
FDA will also have to deal w/ mobile devices being used as medical devices: http://goo.gl/QyuqY (via @) #socpharm

:
The “Bad Ad” campaign erupted out of the FDA being unable to handle the compliance need #socpharm

:
Mobile is a whole separate issue! We discussed that last month, and the difficult of regulating diagnostic tools #socpharm

:
As for the FDA people: Hard work never killed anyone, but why chance it? #socpharm

:
In last few minutes, anyone have any particularly insightful articles or thoughts to share? #socpharm

:
Think about the thousands — tens of thousands — of pharma delivered ads across multiple modalities #socpharm

:
Sometimes too much to drink isn’t enough when it comes to the FDA and SM #socpharm

:
RT @: Think about the thousands — tens of thousands — of pharma delivered ads across multiple modalities #socpharm

:
RT @: Sometimes too much to drink isn’t enough when it comes to the FDA and SM #socpharm

:
@ Agree it’s an almost overwhelming task. #socpharm

:
At the end of the day pharma should perhaps steer clear of social media, and let the advocacy groups & physician groups handle it #socpharm

:
@ What change will GOP Congress make in FDA? #socpharm

:
@ @ The GOP Congress will have BIG influence over the FDA, not only in funding but in spirit #socpharm

:
@ Social media LISTENING & learning is still essential for pharma. Plus partnering with trust agents is viable. #socpharm

:
Yes RT @: pharma should perhaps steer clear of social media, and let the advocacy groups & physician groups handle it #socpharm

:
Better to understand a little than to misunderstand a lot when it comes to health and SM #socpharm

:
@ Agreed! But actually designing and launching healthcare social media platforms pharma should stand down #socpharm

:
EOB, any thoughts about idea of the novartis “pill chip” and sm working together (or not) #socpharm

:
@ Remember though, the GOP only controls half of Congress. The Democrats still control the Senate and White House. #socpharm

:
Thanks everyone and remember as long as we think of patients we will be successful in what we do #socpharm

:
@ Now if the GOP retakes the Senate and/or beats Obama in ’12, then it’s a different story. #socpharm

:
@ The Democrats will now have to compromise, and money in general is scarce with our $12 trillion deficit growing #socpharm

:
RT @: Great things are only possible with outrageous requests. Who is willing ? #socpharm

:
RT @ @ Agreed! But designing and launching healthcare social media platforms pharma should stand down #socpharm

:
Improving patient outcomes and quality of life is what this whole show is about! #socpharm

:
Yes! Agreed! RT @: Thanks everyone and remember as long as we think of patients we will be successful in what we do #socpharm

:
@ Not ready to give it up yet. Have personally witnessed pharma success w/ Pku.com which is v. valuable #socpharm

:
Great words RT @: Thanks everyone and remember as long as we think of patients we will be successful in what we do #socpharm

:
@ Thanks for checking in! Hope to see you next week when @ will be guest moderating #socpharm.

:
Thanks to @ and the whole #socpharm gang for another lively tweetchat!

:
I think I need another glass of wine after the FDA discussion! Thx for sharing great insights and providing food for thought :) #socpharm

:
RT @: Thanks to @ and the whole #socpharm gang for another lively tweetchat! #socpharm

:
Thanks to everyone who joined in tonight for another lively discussion. Get ready for guest moderator @ from Shire next Wed. #socpharm

:
Thanks all & amen RT @: Thanks everyone and remember as long as we think of patients we will be successful in what we do #socpharm

:
@ Interesting question. It is a bit “big brotherish” but if it can help adherence…. #socpharm

:
@ Thank you! #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com